Ventilator-associated pneumonia;Ventilator-assoziierte Pneumonie

Deutsche Medizinische Wochenschrift

Volumn 139, Issue 6, 2014, Pages 251-254

  Klapdor, B ^a   Ewig, S ^a  

^a Augusta Kranken Anstalt   (Germany)

Author keywords

antimicrobial therapy; gram negative bacteria; MDR; Methicillin resistant Staphylococcus aureus; multidrug resistant pathogens; ventilator associated pneumonia

Indexed keywords

NOTE; VENTILATOR ASSOCIATED PNEUMONIA;

ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; MALE; PNEUMONIA, VENTILATOR-ASSOCIATED; PREVALENCE; RESPIRATION, ARTIFICIAL; RISK FACTORS;

EID: 84893598291     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-0033-1359994     Document Type: Note

References (20)

1. Berton D. C., Kalil A. C., Teixeira P. JZ. Quantitative versus qualitative cultures of respiratory secretions for clinical outcomes in patients with ventilator-associated pneumonia. Cochrane Database Syst Rev: 2012; 1 CD006482
2. Blot S., Koulenti D., Dimopoulos G. et al. and the EU-VAP Study Investigators Prevalence, risk factors, and mortality for ventilator-associated pneumonia in middle-aged, old, and very old critically ill patients. Crit Care Med: 2013; Oct 23. [Epub ahead of print]
3. Capellier G., Mockly H., Charpentier C. et al. Early-onset ventilator-associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15 days of antibiotic treatment. PLoS ONE: 2012; 7 e41290
4. Craven D. E., Lei Y., Ruthazer R. et al. Incidence and outcomes of ventilator-associated tracheobronchitis and pneumonia. Am J Med: 2013; 126 542 549
5. Dalfino L., Puntillo F., Mosca A. et al. High-dose, extended-interval colistin administration in critically ill patients: is this the right dosing strategy? A preliminary study. Clin Infect Dis: 2012; 54 1720 1726
6. Dalhoff K., Abele-Horn M., Andreas S. et al. Epidemiologie, Diagnostik und Therapie erwachsener Patienten mit nosokomialer Pneumonie. Pneumologie: 2012; 66 707 765
7. Durante-Mangoni E., Signoriello G., Andini R. et al. Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trial. Clin Infect Dis: 2013; 57 349 358
8. Ewig S., Torres A., El-Ebiary M. et al. Bacterial colonization patterns in mechanically ventilated patients with traumatic and medical head injury. Incidence, risk factors, and association with ventilator-associated pneumonia. Am J Respir Crit Care Med: 1999; 159 188 198 (Pubitemid 29036523)
9. Florescu D. F., Qiu F., McCartan M. A. et al. What is the efficacy and safety of colistin for the treatment of ventilator-associated pneumonia? A systematic review and meta-regression. Clin Infect Dis: 2012; 54 670 680
10. Hill D. M., Schroeppel T. J., Magnotti L. J. et al. Methicillin-resistant Staphylococcus aureus in early ventilator-associated pneumonia: cause for concern? Surg Infect: 2013; Oct 11. [Epub ahead of print]
11. Lu Q., Luo R., Bodin L. et al. Efficacy of high-dose nebulized colistin in ventilator-associated pneumonia caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Anesthesiology: 2012; 117 1335 1347
12. Martin-Loeches I., Deja M., Koulenti D. et al. Potentially resistant microorganisms in intubated patients with hospital-acquired pneumonia: the interaction of ecology, shock and risk factors. Intens Care Med: 2013; 39 672 681
13. Melsen W. G., Rovers M. M., Groenwold R. HH et al. Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies. Lancet Infect Dis: 2013; 13 665 671
14. O'Horo J. C., Thompson D., Safdar N. Is the gram stain useful in the microbiologic diagnosis of VAP? A meta-analysis. Clin Infect Dis: 2012; 55 551 561
15. Papazian L., Roch A., Charles P. E. et al. STATIN-VAP Study Group Effect of statin therapy on mortality in patients with ventilator-associated pneumonia: a randomized clinical trial. JAMA: 2013; 310 1692 1700
16. Ranzani O. T., Ferrer M., Esperatti M. et al. Association between systemic corticosteroids and outcomes of intensive care unit-acquired pneumonia. Crit Care Med: 2012; 40 2552 2561
17. Restrepo M. I., Peterson J., Fernandez J. F. et al. Comparison of the bacterial etiology of early-onset and late-onset ventilator-associated pneumonia in subjects enrolled in 2 large clinical studies. Respir Care: 2013; 58 1220 1225
18. Stevens J. P., Kachniarz B., Wright S. B. et al. When policy gets it right: variability in U.S. hospitals' diagnosis of ventilator-associated pneumonia. Crit Care Med: 2013; Oct 18. [Epub ahead of print]
19. Stocker D. H., Kern W. V. Colistin. Internist: 2013; 54 936 944
20. Wunderink R. G., Niederman M. S., Kollef M. H. et al. Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. Clin Infect Dis: 2012; 54 621 629